Fifth Third Wealth Advisors LLC
- SEC CIK
- 0001899030
- Latest filing
- Jul 17, 2026
LCTX holding history
Lineage Cell Therapeutics, Inc. in every 13F filed by Fifth Third Wealth Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −20,000−100.0% | Sold out | Holders |
| Q2 2025 | 20,000 | $18.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 20,000 | $9.03K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 20,000 | $10.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 20,000 | $18.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 20,000 | $19.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 20,000 | $29.6K | <0.1% | +20,000 | New | Holders |